Ipca Laboratories (NSE:IPCALAB) YoY EBITDA Growth : 70.97% (As of Dec. 2023)

View and export this data going back to 1995. Start your Free Trial

What is Ipca Laboratories YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Ipca Laboratories's YoY EBITDA Growth for the quarter that ended in Dec. 2023 was 70.97%.

Ipca Laboratories's EBITDA per Share for the three months ended in Dec. 2023 was ₹16.63.

Ipca Laboratories YoY EBITDA Growth Historical Data

The historical data trend for Ipca Laboratories's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ipca Laboratories YoY EBITDA Growth Chart

Ipca Laboratories Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

YoY EBITDA Growth

Get a 7-Day Free Trial

51.82

29.07

66.20

-14.54

-23.52

Ipca Laboratories Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
YoY EBITDA Growth	Get a 7-Day Free Trial															-23.05	-7.05	21.00	21.30	70.97

Ipca Laboratories YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Ipca Laboratories's YoY EBITDA Growth for the fiscal year that ended in Mar. 2023 is calculated as:

	YoY EBITDA Growth (A: Mar. 2023 )
=	(EBITDA per Share (A: Mar. 2023 )	-	EBITDA per Share (A: Mar. 2022 ))	/	\| EBITDA per Share (A: Mar. 2022 ) \|
=	(41.463	-	54.212)	/	\| 54.212 \|
=	-23.52 %

Ipca Laboratories's YoY EBITDA Growth for the quarter that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (Q: Dec. 2023 )
=	(EBITDA per Share (Q: Dec. 2023 )	-	EBITDA per Share (Q: Dec. 2022 ))	/	\| EBITDA per Share (Q: Dec. 2022 )) \|
=	(16.625	-	9.724)	/	\| 9.724 \|
=	70.97 %

Ipca Laboratories YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Ipca Laboratories's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Ipca Laboratories (NSE:IPCALAB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ipca Laboratories Ltd (NSE:IPCALAB) » Definitions » YoY EBITDA Growth

Traded in Other Exchanges

524494:India

Address

125, Kandivli Industrial Estate, Kandivli (West), Mumbai, MH, IND, 400067

Website

https://www.ipca.com

Ipca Laboratories Ltd is a specialty and generic drug manufacturing company. The company's principal activity is Development, Manufacturing and Marketing of Pharmaceuticals Products. The company operates multiple subsidiaries with revenue generation split roughly between India and the rest of the world. Ipca's products are exported to more than 100 countries across the globe. Ipca has only one reportable primary business segment, pharmaceuticals.

Ipca Laboratories (NSE:IPCALAB) Headlines

No Headlines